Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Terns Pharmaceuticals, Inc. (TERN)  
$8.23 0.20 (2.49%) as of 4:30 Fri 10/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 84,000,000
Market Cap: 691.32(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2 - $8.27
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8.9
Insider 3/6 Months : 9.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address diseases, such as non-alcoholic steatohepatitis (NASH) and obesity. Co.'s primary program is TERN-101, a liver-distributed, non-bile acid Farnesoid X Receptor (FXR) agonist that has demonstrated sustained liver FXR activation, as well as a favorable tolerability profile across multiple clinical trials. Co.'s another clinical stage program, TERN-201, is an inhibitor of Vascular Adhesion Protein-1. Co. is also evaluating the potential to co-administer TERN-201 in combination with a metabolically active NASH treatment.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 48,314 66,524 553,782
Total Buy Value $0 $186,596 $311,168 $5,359,325
Total People Bought 0 2 3 6
Total Buy Transactions 0 4 7 12
Total Shares Sold 944 1,797 39,418 629,409
Total Sell Value $7,407 $11,047 $224,504 $4,688,233
Total People Sold 1 1 3 6
Total Sell Transactions 1 2 8 21
End Date 2025-07-06 2025-04-04 2024-10-04 2023-10-05

   
Records found: 77
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kuriakose Emil Chief Medical Officer   •       –      –    2025-10-01 4 S $7.85 $7,407 D/D (944) 51,520 -3%     
   Kuriakose Emil Chief Medical Officer   •       –      –    2025-07-01 4 S $4.27 $3,640 D/D (853) 52,464 -109%     
   Gengos Andrew Chief Financial Officer   •       –      –    2025-06-27 4 B $3.93 $39,283 D/D 10,000 25,000 0.01 110%     
   Burroughs Amy L. Chief Executive Officer   •       •      –    2025-06-25 4 B $3.87 $90,230 D/D 23,314 47,083 0.01 98%     
   Gengos Andrew Chief Financial Officer   •       –      –    2025-06-16 4 B $3.95 $19,733 D/D 5,000 15,000 0.01 100%     
   Gengos Andrew Chief Financial Officer   •       –      –    2025-06-13 4 B $3.72 $37,350 D/D 10,000 10,000 0.01 107%     
   Kuriakose Emil Chief Medical Officer   •       –      –    2025-04-01 4 S $2.49 $2,366 D/D (952) 53,317 -146%     
   Strauss David Eric Principal Accounting Officer   •       –      –    2025-02-01 3 IO $0.00 $0 D/D 0 89,673 -10%     
   Vignola Mark J. Chief Financial Officer   •       –      –    2025-01-06 4 AS $5.80 $52,500 D/D (9,059) 74,752 -50%     
   Quigley Jill M.   –       •      –    2025-01-06 4 AS $5.79 $50,758 D/D (8,760) 0 -50%     
   Vignola Mark J. Chief Financial Officer   •       –      –    2025-01-02 4 AS $5.72 $46,524 D/D (8,129) 83,811 -51%     
   Kuriakose Emil Chief Medical Officer   •       –      –    2025-01-02 4 S $5.71 $25,607 D/D (4,481) 54,269 51%     
   Quigley Jill M.   –       •      –    2025-01-02 4 AS $5.72 $35,702 D/D (6,240) 8,760 -51%     
   Burroughs Amy L. Chief Executive Officer   •       •      –    2024-12-05 4 B $7.15 $110,468 D/D 15,450 19,099 0.01 -63%     
   Jung Melita Sun Chief Business Officer   •       –      –    2024-11-30 4 B $5.11 $11,498 D/D 2,250 2,250 0.01 -62%     
   Burroughs Amy L. Chief Executive Officer   •       •      –    2024-11-30 4 B $5.11 $2,606 D/D 510 19,609 0.01 -62%     
   Lu Hongbo Director   –       •      –    2024-09-12 4 B $10.50 $4,999,995 I/I 476,190 476,190 2.1 -51%     
   Vignola Mark J. Chief Financial Officer   •       –      –    2024-09-10 4 AS $11.00 $110,000 D/D (10,000) 91,940 -60%     
   Vignola Mark J. Chief Financial Officer   •       –      –    2024-09-10 4 OE $5.36 $53,600 D/D 10,000 101,940     -
   Quigley Jill M.   –       •      –    2024-09-09 4 AS $10.00 $172,350 D/D (17,235) 15,000 -51%     
   Quigley Jill M.   –       •      –    2024-09-09 4 OE $1.82 $31,368 D/D 17,235 32,235     -
   Quigley Jill M.   –       •      –    2024-08-02 4 AS $7.50 $66,432 D/D (8,857) 15,000 -10%     
   Quigley Jill M.   –       •      –    2024-08-01 4 AS $7.68 $47,148 D/D (6,143) 23,857 -11%     
   Quigley Jill M.   –       •      –    2024-07-16 4 AS $10.00 $4,000 D/D (400) 30,000 -41%     
   Quigley Jill M.   –       •      –    2024-07-16 4 OE $1.82 $728 D/D 400 30,400     -
  77 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us